PR

Upperton Pharma Solutions Win’s Prestigious King’s Award for Enterprise: International Trade 2023

by
Upperton King's Award Presentation Photo

Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development and manufacture of innovative drug formulations, has been announced as a winner of the King’s Award for Enterprise, International Trade. The King’s Award for Enterprise is a highly prestigious award for UK businesses who have demonstrated outstanding innovation in their industry. … Read more

Upperton completes build of new £15m development and GMP manufacturing facility

by

Leading UK contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has completed the build of its new development and GMP manufacturing headquarters in Nottingham, UK. Situated less than two miles from Upperton’s current HQ, the facility ‘Trent Gateway’ houses ten new GMP manufacturing suites, quality control laboratories and formulation development with pilot plant capabilities. … Read more

Nasal Inhalation Delivery – An Introduction Guide

by

An introduction to nasal delivery The delivery of APIs via nasal inhalation is of growing interest to companies looking to exploit the benefits of this delivery route. Delivery targets are typically broken down into three categories Local delivery to the nasal membranes (e.g. for vaccines, antivirals, prophylactics) Systemic delivery by absorption into the bloodstream (e.g. … Read more

Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ

by

20th April 2023 : Press Release Nottingham, UK, 20th April: Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK. Part of Upperton’s £15m investment program announced in January this year, the state-of-the-art facility has benefited from a … Read more

Nasally Delivered Dry Powder Dosage Forms: Particle Size Analysis

by

Introduction to Nasal Delivery The delivery of APIs via nasal inhalation is of growing interest to companies looking to exploit the benefits of this delivery route.Delivery targets are typically broken down into three categories Local delivery to the nasal membranes (e.g. for vaccines, antivirals, prophylactics) Systemic delivery by absorption into the bloodstream (e.g. for fast … Read more

Upperton’s new Nottingham facility

by

18th January 2023 Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has begun construction work for its new Development and GMP Manufacturing headquarters in Nottingham, UK. Working in close collaboration with its principal Design and Build contractor, T-SQUARED the team officially broke ground on the … Read more

Build of New Development and Manufacturing Facility

by

29th November 2022 – Press Release & Newsletter Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has appointed T-SQUARED, UK based company, as the principal Design and Build contractor for … Read more

Upperton Launches ASAPprime® Shelf-Life Stability Testing

by

November 16th 2022 : Newsletter Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients state of the art stability testing. This exciting new platform can be used to generate robust, accelerated chemical stability data and is now being applied at all stages of the product … Read more

In Vitro Testing of Dry Powder Nasal Delivery Devices

by

Successful nasal drug delivery of dry powder formulations requires a delivered dose that can penetrate beyond the nasal entrance region and deposit in the peripheral nasal cavity, whilst avoiding deeper penetration to the airways of the lungs. This delivery, or deposition pattern, is determined by the aerodynamic particle size of the powder exiting the device, … Read more

Linkedin

Driven by experts, led by science

Kings Award for Enterprise - Internal Trade 2023 Logo
award-sunday-times-hundred
award-medilink-outstanding
award-medilink-export
award-medilink-uk-outstanding (1)
award-pharma-uk-large-project (1)

Integrated CDMO services

Events

Development Platforms

Route of delivery

By Development Stage

About Us

Our Approach

Resources

Policies

Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA, UK.  Phone: +44 (0) 115 855 7050  Email: contact@upperton.com

Copyright © 2024 Upperton Limited. All rights reserved.

Let's Talk.

Book a discovery call.

Speak with our team of experts and set up a discovery call to discuss your project in more detail.